Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mohammad Hirmand


  • Evp And Chief Medical Officer at Turning Point Therapeutics Inc. (TPTX), 2019-12-03
  • Interim Chief Medical Officer at Medivation Inc. (MDVN), 2016-09-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MDVN $41.10 1,525 Officer 39,342 2016-03-04 Filing
MDVN $43.40 1,075 Officer 31,113 2015-12-03 Filing
MDVN $41.91 232 Officer 32,188 2015-11-09 Filing